{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T09:18:25Z","timestamp":1792660705610,"version":"4.5.0"},"reference-count":134,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","atherosclerosis-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1016\/j.atherosclerosis.2015.09.032","type":"journal-article","created":{"date-parts":[[2015,10,2]],"date-time":"2015-10-02T03:22:44Z","timestamp":1443756164000},"page":"449-461","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":283,"title":["Berberine, a plant alkaloid with lipid- and glucose-lowering properties: From in\u00a0vitro evidence to clinical studies"],"prefix":"10.1016","volume":"243","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2948-6257","authenticated-orcid":false,"given":"Angela","family":"Pirillo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberico Luigi","family":"Catapano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2015.09.032_bib1","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1002\/ptr.2399","article-title":"Pharmacological and therapeutic effects of Berberis vulgaris and its active constituent, berberine","volume":"22","author":"Imanshahidi","year":"2008","journal-title":"Phytother. Res."},{"key":"10.1016\/j.atherosclerosis.2015.09.032_bib2","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1124\/dmd.108.021659","article-title":"Isolation and identification of urinary metabolites of berberine in rats and humans","volume":"36","author":"Qiu","year":"2008","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.atherosclerosis.2015.09.032_bib3","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1124\/dmd.110.033936","article-title":"Extensive intestinal first-pass elimination and predominant hepatic distribution of berberine explain its low plasma levels in rats","volume":"38","author":"Liu","year":"2010","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.atherosclerosis.2015.09.032_bib4","doi-asserted-by":"crossref","first-page":"e77969","DOI":"10.1371\/journal.pone.0077969","article-title":"Tissue distribution of berberine and its metabolites after oral administration in rats","volume":"8","author":"Tan","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.atherosclerosis.2015.09.032_bib5","doi-asserted-by":"crossref","first-page":"4391","DOI":"10.1002\/jps.21721","article-title":"Oxidative demethylenation and subsequent glucuronidation are the major metabolic pathways of berberine in rats","volume":"98","author":"Liu","year":"2009","journal-title":"J.\u00a0Pharm. Sci."},{"key":"10.1016\/j.atherosclerosis.2015.09.032_bib6","doi-asserted-by":"crossref","first-page":"2614","DOI":"10.1002\/jps.10268","article-title":"P-glycoprotein-mediated transport of berberine across Caco-2 cell monolayers","volume":"91","author":"Maeng","year":"2002","journal-title":"J.\u00a0Pharm. Sci."},{"key":"10.1016\/j.atherosclerosis.2015.09.032_bib7","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1271\/bbb.60441","article-title":"Human MDR1 and MRP1 recognize berberine as their transport substrate","volume":"71","author":"Shitan","year":"2007","journal-title":"Biosci. Biotechnol. Biochem."},{"key":"10.1016\/j.atherosclerosis.2015.09.032_bib8","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1034\/j.1600-0773.2002.t01-1-910403.x","article-title":"The involvement of P-glycoprotein in berberine absorption","volume":"91","author":"Pan","year":"2002","journal-title":"Pharmacol. Toxicol."},{"key":"10.1016\/j.atherosclerosis.2015.09.032_bib9","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1007\/s12272-014-0510-6","article-title":"Organic cation transporter-mediated drug-drug interaction potential between berberine and metformin","volume":"38","author":"Kwon","year":"2015","journal-title":"Arch. Pharm. Res."},{"issue":"Pt A","key":"10.1016\/j.atherosclerosis.2015.09.032_bib10","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.jep.2014.10.018","article-title":"In\u00a0vitro studies of berberine metabolism and its effect of enzyme induction on HepG2 cells","volume":"158","author":"Cui","year":"2014","journal-title":"J.\u00a0Ethnopharmacol."},{"key":"10.1016\/j.atherosclerosis.2015.09.032_bib11","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s00228-011-1108-2","article-title":"Repeated administration of berberine inhibits cytochromes P450 in humans","volume":"68","author":"Guo","year":"2011","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.atherosclerosis.2015.09.032_bib12","first-page":"145325","article-title":"Cyclosporine and herbal supplement interactions","volume":"2014","author":"Colombo","year":"2014","journal-title":"J.\u00a0Toxicol."},{"key":"10.1016\/j.atherosclerosis.2015.09.032_bib13","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1007\/s00228-013-1537-1","article-title":"Pharmacokinetic interaction between tacrolimus and berberine in a child with idiopathic nephrotic syndrome","volume":"69","author":"Hou","year":"2013","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.atherosclerosis.2015.09.032_bib14","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1124\/mol.114.095810","article-title":"Adenosine monophosphate-activated kinase and its key role in catabolism: structure, regulation, biological activity, and pharmacological activation","volume":"87","author":"Krishan","year":"2015","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.atherosclerosis.2015.09.032_bib15","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1038\/nm1135","article-title":"Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins","volume":"10","author":"Kong","year":"2004","journal-title":"Nat. Med."},{"key":"10.1016\/j.atherosclerosis.2015.09.032_bib16","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1248\/bpb.b14-00412","article-title":"Berberine up-regulates hepatic low-density lipoprotein receptor through Ras-independent but AMP-activated protein kinase-dependent Raf-1 activation","volume":"37","author":"Li","year":"2014","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.atherosclerosis.2015.09.032_bib17","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.bbrc.2007.08.060","article-title":"Berberine-induced LDLR up-regulation involves JNK pathway","volume":"362","author":"Lee","year":"2007","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.atherosclerosis.2015.09.032_bib18","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1161\/CIRCRESAHA.114.301621","article-title":"PCSK9: a key modulator of cardiovascular health","volume":"114","author":"Seidah","year":"2014","journal-title":"Circ. Res."},{"key":"10.1016\/j.atherosclerosis.2015.09.032_bib19","doi-asserted-by":"crossref","DOI":"10.1111\/dom.12536","article-title":"Effect of statin therapy on plasma PCSK9 concentrations: a systematic review and meta-analysis of clinical trials","author":"Sahebkar","year":"2015","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.atherosclerosis.2015.09.032_bib20","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.atherosclerosis.2008.02.004","article-title":"Berberine decreases PCSK9 expression in HepG2 cells","volume":"201","author":"Cameron","year":"2008","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2015.09.032_bib21","doi-asserted-by":"crossref","first-page":"28885","DOI":"10.1074\/jbc.M109.052407","article-title":"Hepatocyte nuclear factor 1alpha plays a critical role in PCSK9 gene transcription and regulation by the natural hypocholesterolemic compound berberine","volume":"284","author":"Li","year":"2009","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.atherosclerosis.2015.09.032_bib22","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1194\/jlr.M600020-JLR200","article-title":"Inhibition of lipid synthesis through activation of AMP kinase: an additional mechanism for the hypolipidemic effects of berberine","volume":"47","author":"Brusq","year":"2006","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.atherosclerosis.2015.09.032_bib23","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.jep.2013.07.025","article-title":"Berberine metabolites exhibit triglyceride-lowering effects via activation of AMP-activated protein kinase in Hep G2 cells","volume":"149","author":"Cao","year":"2013","journal-title":"J.\u00a0Ethnopharmacol."},{"key":"10.1016\/j.atherosclerosis.2015.09.032_bib24","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.ejphar.2010.10.051","article-title":"Role of JNK and c-Jun signaling pathway in regulation of human serum paraoxonase 1 gene transcription by berberine in human HepG2 cells","volume":"650","author":"Cheng","year":"2011","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.atherosclerosis.2015.09.032_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejphar.2015.03.013","article-title":"Berberine reduces Toll-like receptor-mediated macrophage migration by suppression of Src enhancement","volume":"757","author":"Cheng","year":"2015","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.atherosclerosis.2015.09.032_bib26","doi-asserted-by":"crossref","first-page":"289264","DOI":"10.1155\/2014\/289264","article-title":"Antioxidant and anti-inflammatory activities of berberine in the treatment of diabetes mellitus","volume":"2014","author":"Li","year":"2014","journal-title":"Evid. Based Complement. Altern. Med."},{"key":"10.1016\/j.atherosclerosis.2015.09.032_bib27","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1139\/Y09-136","article-title":"Berberine inhibits NADPH oxidase mediated superoxide anion production in macrophages","volume":"88","author":"Sarna","year":"2010","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"10.1016\/j.atherosclerosis.2015.09.032_bib28","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.bbrc.2012.12.143","article-title":"Inhibitory effects of berberine on lipopolysaccharide-induced inducible nitric oxide synthase and the high-mobility group box 1 release in macrophages","volume":"431","author":"Lee","year":"2013","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.atherosclerosis.2015.09.032_bib29","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1089\/ars.2012.5116","article-title":"The crosstalk between Nrf2 and AMPK signal pathways is important for the anti-inflammatory effect of berberine in LPS-stimulated macrophages and endotoxin-shocked mice","volume":"20","author":"Mo","year":"2014","journal-title":"Antioxid. Redox. Signal"},{"key":"10.1016\/j.atherosclerosis.2015.09.032_bib30","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1186\/s12967-015-0450-z","article-title":"Berberine alleviates ox-LDL induced inflammatory factors by up-regulation of autophagy via AMPK\/mTOR signaling pathway","volume":"13","author":"Fan","year":"2015","journal-title":"J.\u00a0Transl. Med."},{"key":"10.1016\/j.atherosclerosis.2015.09.032_bib31","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1002\/ar.21489","article-title":"Suppression of oxLDL-induced MMP-9 and EMMPRIN expression by berberine via inhibition of NF-kappaB activation in human THP-1 macrophages","volume":"295","author":"Huang","year":"2012","journal-title":"Anat. Rec. Hob."},{"key":"10.1016\/j.atherosclerosis.2015.09.032_bib32","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.ijcard.2009.06.023","article-title":"Berberine reduces both MMP-9 and EMMPRIN expression through prevention of p38 pathway activation in PMA-induced macrophages","volume":"146","author":"Huang","year":"2011","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2015.09.032_bib33","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1142\/S0192415X10008548","article-title":"Effects of berberine on expression of LOX-1 and SR-BI in human macrophage-derived foam cells induced by ox-LDL","volume":"38","author":"Guan","year":"2010","journal-title":"Am. J. Chin. Med."},{"key":"10.1016\/j.atherosclerosis.2015.09.032_bib34","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1002\/jcb.22667","article-title":"Anti-atherogenic effect of berberine on LXRalpha-ABCA1-dependent cholesterol efflux in macrophages","volume":"111","author":"Lee","year":"2010","journal-title":"J.\u00a0Cell Biochem."},{"key":"10.1016\/j.atherosclerosis.2015.09.032_bib35","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.numecd.2014.08.004","article-title":"The natural compound berberine positively affects macrophage functions involved in atherogenesis","volume":"25","author":"Zimetti","year":"2015","journal-title":"Nutr. Metab. Cardiovasc Dis."},{"key":"10.1016\/j.atherosclerosis.2015.09.032_bib36","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S1016-8478(23)13249-3","article-title":"Berberine inhibits the production of lysophosphatidylcholine-induced reactive oxygen species and the ERK1\/2 pathway in vascular smooth muscle cells","volume":"20","author":"Cho","year":"2005","journal-title":"Mol. Cells"},{"key":"10.1016\/j.atherosclerosis.2015.09.032_bib37","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.atherosclerosis.2005.06.048","article-title":"Berberine inhibits rat vascular smooth muscle cell proliferation and migration in\u00a0vitro and improves neointima formation after balloon injury in\u00a0vivo. Berberine improves neointima formation in a rat model","volume":"186","author":"Lee","year":"2006","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2015.09.032_bib38","doi-asserted-by":"crossref","first-page":"824","DOI":"10.4330\/wjc.v6.i8.824","article-title":"Is reversal of endothelial dysfunction still an attractive target in modern cardiology?","volume":"6","author":"Mordi","year":"2014","journal-title":"World J. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2015.09.032_bib39","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.vph.2007.06.004","article-title":"Inhibitory effects of zoagumhwan water extract and berberine on angiotensin II-induced monocyte chemoattractant protein (MCP)-1 expression and monocyte adhesion to endothelial cells","volume":"47","author":"Ko","year":"2007","journal-title":"Vasc. Pharmacol."},{"key":"10.1016\/j.atherosclerosis.2015.09.032_bib40","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1177\/039463201202500320","article-title":"Berberine reduces leukocyte adhesion to LPS-stimulated endothelial cells and VCAM-1 expression both in\u00a0vivo and in\u00a0vitro","volume":"25","author":"Wu","year":"2012","journal-title":"Int. J. Immunopathol. Pharmacol."},{"key":"10.1016\/j.atherosclerosis.2015.09.032_bib41","doi-asserted-by":"crossref","first-page":"260464","DOI":"10.1155\/2013\/260464","article-title":"Berberine protects against palmitate-induced endothelial dysfunction: involvements of upregulation of AMPK and eNOS and downregulation of NOX4","volume":"2013","author":"Zhang","year":"2013","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.atherosclerosis.2015.09.032_bib42","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1093\/cvr\/cvp078","article-title":"Berberine prevents hyperglycemia-induced endothelial injury and enhances vasodilatation via adenosine monophosphate-activated protein kinase and endothelial nitric oxide synthase","volume":"82","author":"Wang","year":"2009","journal-title":"Cardiovasc Res."},{"key":"10.1016\/j.atherosclerosis.2015.09.032_bib43","first-page":"2092","article-title":"Leukocytes from diabetic patients kill retinal endothelial cells: effects of berberine","volume":"19","author":"Tian","year":"2013","journal-title":"Mol. Vis."},{"key":"10.1016\/j.atherosclerosis.2015.09.032_bib44","doi-asserted-by":"crossref","first-page":"2530","DOI":"10.1161\/01.ATV.0000243941.72375.15","article-title":"Increased ratio of CD31+\/CD42- microparticles to endothelial progenitors as a novel marker of atherosclerosis in hypercholesterolemia","volume":"26","author":"Pirro","year":"2006","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2015.09.032_bib45","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/sj.jhh.1002311","article-title":"Berberine-induced mobilization of circulating endothelial progenitor cells improves human small artery elasticity","volume":"22","author":"Xu","year":"2008","journal-title":"J.\u00a0Hum. Hypertens."},{"key":"10.1016\/j.atherosclerosis.2015.09.032_bib46","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1159\/000157336","article-title":"Berberine-induced upregulation of circulating endothelial progenitor cells is related to nitric oxide production in healthy subjects","volume":"112","author":"Xu","year":"2009","journal-title":"Cardiology"},{"key":"10.1016\/j.atherosclerosis.2015.09.032_bib47","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ejphar.2014.09.024","article-title":"Berberine protects endothelial progenitor cell from damage of TNF-alpha via the PI3K\/AKT\/eNOS signaling pathway","volume":"743","author":"Xiao","year":"2014","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.atherosclerosis.2015.09.032_bib48","doi-asserted-by":"crossref","first-page":"3246","DOI":"10.1111\/bph.12666","article-title":"Uncoupling protein-2 mediates the protective action of berberine against oxidative stress in rat insulinoma INS-1E cells and in diabetic mouse islets","volume":"171","author":"Liu","year":"2014","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.atherosclerosis.2015.09.032_bib49","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.metabol.2009.07.029","article-title":"Berberine lowers blood glucose in type 2 diabetes mellitus patients through increasing insulin receptor expression","volume":"59","author":"Zhang","year":"2010","journal-title":"Metabolism"},{"key":"10.1016\/j.atherosclerosis.2015.09.032_bib50","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.ejphar.2012.07.052","article-title":"Berberine inhibits mouse insulin gene promoter through activation of AMP activated protein kinase and may exert beneficial effect on pancreatic beta-cell","volume":"694","author":"Shen","year":"2012","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.atherosclerosis.2015.09.032_bib51","doi-asserted-by":"crossref","first-page":"E148","DOI":"10.1152\/ajpendo.00211.2007","article-title":"Berberine improves glucose metabolism through induction of glycolysis","volume":"294","author":"Yin","year":"2008","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.atherosclerosis.2015.09.032_bib52","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1248\/bpb.30.2120","article-title":"Berberine activates GLUT1-mediated glucose uptake in 3T3-L1 adipocytes","volume":"30","author":"Kim","year":"2007","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.atherosclerosis.2015.09.032_bib53","doi-asserted-by":"crossref","DOI":"10.1155\/2011\/924851","article-title":"Berberine moderates glucose and lipid metabolism through multipathway mechanism","volume":"2011","author":"Zhang","year":"2011","journal-title":"Evid. Based Complement. Altern. Med."},{"key":"10.1016\/j.atherosclerosis.2015.09.032_bib54","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1055\/s-2003-41121","article-title":"The antihyperglycaemic activity of berberine arises from a decrease of glucose absorption","volume":"69","author":"Pan","year":"2003","journal-title":"Planta Med."},{"key":"10.1016\/j.atherosclerosis.2015.09.032_bib55","doi-asserted-by":"crossref","first-page":"E955","DOI":"10.1152\/ajpendo.90599.2008","article-title":"Berberine suppresses proinflammatory responses through AMPK activation in macrophages","volume":"296","author":"Jeong","year":"2009","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.atherosclerosis.2015.09.032_bib56","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.bbadis.2010.10.001","article-title":"Berberine attenuates cAMP-induced lipolysis via reducing the inhibition of phosphodiesterase in 3T3-L1 adipocytes","volume":"1812","author":"Zhou","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.atherosclerosis.2015.09.032_bib57","doi-asserted-by":"crossref","first-page":"e0125667","DOI":"10.1371\/journal.pone.0125667","article-title":"Berberine suppresses adipocyte differentiation via decreasing CREB transcriptional activity","volume":"10","author":"Zhang","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.atherosclerosis.2015.09.032_bib58","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/j.phymed.2009.03.002","article-title":"Berberine increases expression of GATA-2 and GATA-3 during inhibition of adipocyte differentiation","volume":"16","author":"Hu","year":"2009","journal-title":"Phytomedicine"},{"key":"10.1016\/j.atherosclerosis.2015.09.032_bib59","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.bbrc.2006.07.095","article-title":"Berberine inhibits 3T3-L1 adipocyte differentiation through the PPARgamma pathway","volume":"348","author":"Huang","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.atherosclerosis.2015.09.032_bib60","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/emm.2006.71","article-title":"Berberine reduces the expression of adipogenic enzymes and inflammatory molecules of 3T3-L1 adipocyte","volume":"38","author":"Choi","year":"2006","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.atherosclerosis.2015.09.032_bib61","doi-asserted-by":"crossref","first-page":"285489","DOI":"10.1155\/2013\/285489","article-title":"Effect of berberine on PPAR alpha\/NO activation in high glucose- and insulin-induced cardiomyocyte hypertrophy","volume":"2013","author":"Wang","year":"2013","journal-title":"Evid. Based Complement. Altern. Med."},{"key":"10.1016\/j.atherosclerosis.2015.09.032_bib62","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/j.metabol.2013.02.007","article-title":"Berberine improves insulin resistance in cardiomyocytes via activation of 5\u2032-adenosine monophosphate-activated protein kinase","volume":"62","author":"Chang","year":"2013","journal-title":"Metabolism"},{"key":"10.1016\/j.atherosclerosis.2015.09.032_bib63","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1007\/s10495-014-0977-0","article-title":"Berberine reduces ischemia\/reperfusion-induced myocardial apoptosis via activating AMPK and PI3K-Akt signaling in diabetic rats","volume":"19","author":"Chen","year":"2014","journal-title":"Apoptosis"},{"key":"10.1016\/j.atherosclerosis.2015.09.032_bib64","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1007\/s10495-015-1122-4","article-title":"Protective effect of berberine against myocardial ischemia reperfusion injury: role of Notch1\/Hes1-PTEN\/Akt signaling","volume":"20","author":"Yu","year":"2015","journal-title":"Apoptosis"},{"key":"10.1016\/j.atherosclerosis.2015.09.032_bib65","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s11010-008-0024-y","article-title":"Berberine reduces fibronectin and collagen accumulation in rat glomerular mesangial cells cultured under high glucose condition","volume":"325","author":"Liu","year":"2009","journal-title":"Mol. Cell Biochem."},{"key":"10.1016\/j.atherosclerosis.2015.09.032_bib66","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.abb.2008.04.022","article-title":"Berberine inhibits aldose reductase and oxidative stress in rat mesangial cells cultured under high glucose","volume":"475","author":"Liu","year":"2008","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.atherosclerosis.2015.09.032_bib67","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.mehy.2012.06.016","article-title":"Possible therapeutic potential of berberine in diabetic osteopathy","volume":"79","author":"Rahigude","year":"2012","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.atherosclerosis.2015.09.032_bib68","doi-asserted-by":"crossref","first-page":"342","DOI":"10.3736\/jcim20090408","article-title":"Effects of berberine on differentiation and bone resorption of osteoclasts derived from rat bone marrow cells","volume":"7","author":"Wei","year":"2009","journal-title":"Zhong Xi Yi Jie He Xue Bao"},{"key":"10.1016\/j.atherosclerosis.2015.09.032_bib69","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1359\/jbmr.080325","article-title":"Berberine promotes osteoblast differentiation by Runx2 activation with p38 MAPK","volume":"23","author":"Lee","year":"2008","journal-title":"J.\u00a0Bone Min. Res."},{"key":"10.1016\/j.atherosclerosis.2015.09.032_bib70","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1530\/JOE-11-0306","article-title":"AMP-activated protein kinase pathway and bone metabolism","volume":"212","author":"Jeyabalan","year":"2012","journal-title":"J.\u00a0Endocrinol."},{"key":"10.1016\/j.atherosclerosis.2015.09.032_bib71","doi-asserted-by":"crossref","first-page":"e25436","DOI":"10.1371\/journal.pone.0025436","article-title":"Activation of AMP-activated protein kinase is required for berberine-induced reduction of atherosclerosis in mice: the role of uncoupling protein 2","volume":"6","author":"Wang","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.atherosclerosis.2015.09.032_bib72","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/j.metabol.2014.05.013","article-title":"Berberine decreases cholesterol levels in rats through multiple mechanisms, including inhibition of cholesterol absorption","volume":"63","author":"Wang","year":"2014","journal-title":"Metabolism"},{"key":"10.1016\/j.atherosclerosis.2015.09.032_bib73","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/1476-511X-11-86","article-title":"The effects of berberine on hyperhomocysteinemia and hyperlipidemia in rats fed with a long-term high-fat diet","volume":"11","author":"Chang","year":"2012","journal-title":"Lipids Health Dis."},{"key":"10.1016\/j.atherosclerosis.2015.09.032_bib74","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S1734-1140(12)70883-6","article-title":"Berberine inhibits dyslipidemia in C57BL\/6 mice with lipopolysaccharide induced inflammation","volume":"64","author":"Xiao","year":"2012","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.atherosclerosis.2015.09.032_bib75","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/j.metabol.2008.01.037","article-title":"Combination of simvastatin with berberine improves the lipid-lowering efficacy","volume":"57","author":"Kong","year":"2008","journal-title":"Metabolism"},{"key":"10.1016\/j.atherosclerosis.2015.09.032_bib76","doi-asserted-by":"crossref","first-page":"e59794","DOI":"10.1371\/journal.pone.0059794","article-title":"Berberine ameliorates chronic kidney injury caused by atherosclerotic renovascular disease through the suppression of NFkappaB signaling pathway in rats","volume":"8","author":"Wan","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.atherosclerosis.2015.09.032_bib77","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0092-8674(00)81106-X","article-title":"Insulin-dependent diabetes mellitus","volume":"85","author":"Tisch","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.atherosclerosis.2015.09.032_bib78","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.intimp.2012.01.003","article-title":"Protective effect of berberine on serum glucose levels in non-obese diabetic mice","volume":"12","author":"Chueh","year":"2012","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.atherosclerosis.2015.09.032_bib79","doi-asserted-by":"crossref","first-page":"8021","DOI":"10.1021\/jf201627w","article-title":"Berberine, an isoquinoline alkaloid in herbal plants, protects pancreatic islets and serum lipids in nonobese diabetic mice","volume":"59","author":"Chueh","year":"2011","journal-title":"J.\u00a0Agric. Food Chem."},{"key":"10.1016\/j.atherosclerosis.2015.09.032_bib80","first-page":"496","article-title":"Therapeutic effects of berberine in impaired glucose tolerance rats and its influence on insulin secretion","volume":"25","author":"Leng","year":"2004","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.atherosclerosis.2015.09.032_bib81","doi-asserted-by":"crossref","first-page":"313808","DOI":"10.1155\/2015\/313808","article-title":"Effects of berberine on amelioration of hyperglycemia and oxidative stress in high glucose and high fat diet-induced diabetic hamsters in\u00a0vivo","volume":"2015","author":"Liu","year":"2015","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.atherosclerosis.2015.09.032_bib82","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1677\/JOE-08-0419","article-title":"Berberine promotes glucagon-like peptide-1 (7-36) amide secretion in streptozotocin-induced diabetic rats","volume":"200","author":"Lu","year":"2009","journal-title":"J.\u00a0Endocrinol."},{"key":"10.1016\/j.atherosclerosis.2015.09.032_bib83","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.metabol.2008.08.013","article-title":"Berberine reduces insulin resistance through protein kinase C-dependent up-regulation of insulin receptor expression","volume":"58","author":"Kong","year":"2009","journal-title":"Metabolism"},{"key":"10.1016\/j.atherosclerosis.2015.09.032_bib84","doi-asserted-by":"crossref","first-page":"e16556","DOI":"10.1371\/journal.pone.0016556","article-title":"Berberine improves glucose metabolism in diabetic rats by inhibition of hepatic gluconeogenesis","volume":"6","author":"Xia","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.atherosclerosis.2015.09.032_bib85","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.2337\/db06-0006","article-title":"Berberine, a natural plant product, activates AMP-activated protein kinase with beneficial metabolic effects in diabetic and insulin-resistant states","volume":"55","author":"Lee","year":"2006","journal-title":"Diabetes"},{"key":"10.1016\/j.atherosclerosis.2015.09.032_bib86","doi-asserted-by":"crossref","first-page":"5493","DOI":"10.1038\/ncomms6493","article-title":"Berberine activates thermogenesis in white and brown adipose tissue","volume":"5","author":"Zhang","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.atherosclerosis.2015.09.032_bib87","doi-asserted-by":"crossref","first-page":"933","DOI":"10.2337\/db11-1164","article-title":"Sustained antidiabetic effects of a berberine-containing Chinese herbal medicine through regulation of hepatic gene expression","volume":"61","author":"Zhao","year":"2012","journal-title":"Diabetes"},{"key":"10.1016\/j.atherosclerosis.2015.09.032_bib88","doi-asserted-by":"crossref","first-page":"E812","DOI":"10.1152\/ajpendo.90710.2008","article-title":"Berberine improves lipid dysregulation in obesity by controlling central and peripheral AMPK activity","volume":"296","author":"Kim","year":"2009","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.atherosclerosis.2015.09.032_bib89","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.ejphar.2011.03.024","article-title":"Berberine attenuates cardiac dysfunction in hyperglycemic and hypercholesterolemic rats","volume":"660","author":"Dong","year":"2011","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.atherosclerosis.2015.09.032_bib90","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ejphar.2015.04.017","article-title":"Berberine as a promising anti-diabetic nephropathy drug: an analysis of its effects and mechanisms","volume":"760","author":"Ni","year":"2015","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.atherosclerosis.2015.09.032_bib91","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.ejphar.2015.07.040","article-title":"Renoprotective effects of berberine through regulation of the MMPs\/TIMPs system in streptozocin-induced diabetic nephropathy in rats","volume":"764","author":"Ni","year":"2015","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.atherosclerosis.2015.09.032_bib92","doi-asserted-by":"crossref","first-page":"76","DOI":"10.2174\/157339912799424564","article-title":"Over-nutrition, obesity and insulin resistance in the development of beta-cell dysfunction","volume":"8","author":"Gupta","year":"2012","journal-title":"Curr. Diabetes Rev."},{"key":"10.1016\/j.atherosclerosis.2015.09.032_bib93","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.fitote.2009.10.010","article-title":"Berberine inhibits adipogenesis in high-fat diet-induced obesity mice","volume":"81","author":"Hu","year":"2010","journal-title":"Fitoterapia"},{"key":"10.1016\/j.atherosclerosis.2015.09.032_bib94","first-page":"505","article-title":"A\u00a0preliminary investigation of the mechanisms underlying the effect of berberine in preventing high-fat diet-induced insulin resistance in rats","volume":"63","author":"Gu","year":"2012","journal-title":"J.\u00a0Physiol. Pharmacol."},{"key":"10.1016\/j.atherosclerosis.2015.09.032_bib95","doi-asserted-by":"crossref","first-page":"RA164","DOI":"10.12659\/MSM.881842","article-title":"Modulating gut microbiota as an anti-diabetic mechanism of berberine","volume":"17","author":"Han","year":"2011","journal-title":"Med. Sci. Monit."},{"key":"10.1016\/j.atherosclerosis.2015.09.032_bib96","doi-asserted-by":"crossref","first-page":"e42529","DOI":"10.1371\/journal.pone.0042529","article-title":"Structural changes of gut microbiota during berberine-mediated prevention of obesity and insulin resistance in high-fat diet-fed rats","volume":"7","author":"Zhang","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.atherosclerosis.2015.09.032_bib97","doi-asserted-by":"crossref","first-page":"e24520","DOI":"10.1371\/journal.pone.0024520","article-title":"Effects and action mechanisms of berberine and Rhizoma coptidis on gut microbes and obesity in high-fat diet-fed C57BL\/6J mice","volume":"6","author":"Xie","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.atherosclerosis.2015.09.032_bib98","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1055\/s-0032-1328321","article-title":"The effects of berberine on blood lipids: a systemic review and meta-analysis of randomized controlled trials","volume":"79","author":"Dong","year":"2013","journal-title":"Planta Med."},{"key":"10.1016\/j.atherosclerosis.2015.09.032_bib99","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1517\/14712598.2013.776037","article-title":"Effects of berberine on lipid profile in subjects with low cardiovascular risk","volume":"13","author":"Derosa","year":"2013","journal-title":"Expert Opin. Biol. Ther."},{"key":"10.1016\/j.atherosclerosis.2015.09.032_bib100","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.numecd.2009.05.017","article-title":"Effects of a nutraceutical combination (berberine, red yeast rice and policosanols) on lipid levels and endothelial function randomized, double-blind, placebo-controlled study","volume":"20","author":"Affuso","year":"2010","journal-title":"Nutr. Metab. Cardiovasc Dis."},{"key":"10.1016\/j.atherosclerosis.2015.09.032_bib101","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1007\/s12325-011-0082-5","article-title":"Long-term effects of nutraceuticals (berberine, red yeast rice, policosanol) in elderly hypercholesterolemic patients","volume":"28","author":"Marazzi","year":"2011","journal-title":"Adv. Ther."},{"key":"10.1016\/j.atherosclerosis.2015.09.032_bib102","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/1476-511X-11-123","article-title":"Nutraceutical pill containing berberine versus ezetimibe on plasma lipid pattern in hypercholesterolemic subjects and its additive effect in patients with familial hypercholesterolemia on stable cholesterol-lowering treatment","volume":"11","author":"Pisciotta","year":"2012","journal-title":"Lipids Health Dis."},{"key":"10.1016\/j.atherosclerosis.2015.09.032_bib103","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.1365-2710.2009.01085.x","article-title":"A\u00a0systematic review and meta-analysis on the therapeutic equivalence of statins","volume":"35","author":"Weng","year":"2010","journal-title":"J.\u00a0Clin. Pharm. Ther."},{"key":"10.1016\/j.atherosclerosis.2015.09.032_bib104","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1089\/acm.2011.0624","article-title":"Combined nutraceutical approach to postmenopausal syndrome and vascular remodeling biomarkers","volume":"19","author":"Cicero","year":"2013","journal-title":"J.\u00a0Altern. Complement. Med."},{"key":"10.1016\/j.atherosclerosis.2015.09.032_bib105","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.metabol.2008.01.013","article-title":"Efficacy of berberine in patients with type 2 diabetes mellitus","volume":"57","author":"Yin","year":"2008","journal-title":"Metabolism"},{"key":"10.1016\/j.atherosclerosis.2015.09.032_bib106","doi-asserted-by":"crossref","first-page":"591654","DOI":"10.1155\/2012\/591654","article-title":"Berberine in the treatment of type 2 diabetes mellitus: a systemic review and meta-analysis","volume":"2012","author":"Dong","year":"2012","journal-title":"Evid. Based Complement. Altern. Med."},{"key":"10.1016\/j.atherosclerosis.2015.09.032_bib107","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1089\/met.2012.0183","article-title":"Effect of berberine administration on metabolic syndrome, insulin sensitivity, and insulin secretion","volume":"11","author":"Perez-Rubio","year":"2013","journal-title":"Metab. Syndr. Relat. Disord."},{"key":"10.1016\/j.atherosclerosis.2015.09.032_bib108","doi-asserted-by":"crossref","first-page":"363845","DOI":"10.1155\/2012\/363845","article-title":"Berberine improves insulin sensitivity by inhibiting fat store and adjusting adipokines profile in human preadipocytes and metabolic syndrome patients","volume":"2012","author":"Yang","year":"2012","journal-title":"Evid. Based Complement. Altern. Med."},{"key":"10.1016\/j.atherosclerosis.2015.09.032_bib109","doi-asserted-by":"crossref","first-page":"77","DOI":"10.4330\/wjc.v4.i3.77","article-title":"A\u00a0nutraceutical combination improves insulin sensitivity in patients with metabolic syndrome","volume":"4","author":"Affuso","year":"2012","journal-title":"World J. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2015.09.032_bib110","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.jpba.2007.03.022","article-title":"Determination of berberine in human plasma by liquid chromatography-electrospray ionization-mass spectrometry","volume":"44","author":"Hua","year":"2007","journal-title":"J.\u00a0Pharm. Biomed. Anal."},{"key":"10.1016\/j.atherosclerosis.2015.09.032_bib111","doi-asserted-by":"crossref","first-page":"213","DOI":"10.2147\/DMSO.S33718","article-title":"Pilot study on the additive effects of berberine and oral type 2 diabetes agents for patients with suboptimal glycemic control","volume":"5","author":"Di Pierro","year":"2012","journal-title":"Diabetes Metab. Syndr. Obes."},{"key":"10.1016\/j.atherosclerosis.2015.09.032_bib112","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1517\/14712598.2013.832751","article-title":"Berberis aristata\/Silybum marianum fixed combination on lipid profile and insulin secretion in dyslipidemic patients","volume":"13","author":"Derosa","year":"2013","journal-title":"Expert Opin. Biol. Ther."},{"key":"10.1016\/j.atherosclerosis.2015.09.032_bib113","first-page":"717","article-title":"Effects of Berberis aristata\/Silybum marianum association on metabolic parameters and adipocytokines in overweight dyslipidemic patients","volume":"27","author":"Derosa","year":"2013","journal-title":"J.\u00a0Biol. Regul. Homeost. Agents"},{"key":"10.1016\/j.atherosclerosis.2015.09.032_bib114","doi-asserted-by":"crossref","first-page":"89","DOI":"10.2147\/DMSO.S78877","article-title":"Clinical role of a fixed combination of standardized Berberis aristata and Silybum marianum extracts in diabetic and hypercholesterolemic patients intolerant to statins","volume":"8","author":"Di Pierro","year":"2015","journal-title":"Diabetes Metab. Syndr. Obes."},{"key":"10.1016\/j.atherosclerosis.2015.09.032_bib115","first-page":"167","article-title":"Preliminary study about the possible glycemic clinical advantage in using a fixed combination of Berberis aristata and Silybum marianum standardized extracts versus only Berberis aristata in patients with type 2 diabetes","volume":"5","author":"Di Pierro","year":"2013","journal-title":"Clin. Pharmacol."},{"key":"10.1016\/j.atherosclerosis.2015.09.032_bib116","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1208\/s12249-010-9386-z","article-title":"Enhancement of sodium caprate on intestine absorption and antidiabetic action of berberine","volume":"11","author":"Lv","year":"2010","journal-title":"AAPS Pharm. Sci. Tech."},{"key":"10.1016\/j.atherosclerosis.2015.09.032_bib117","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.mce.2012.08.006","article-title":"Sodium caprate augments the hypoglycemic effect of berberine via AMPK in inhibiting hepatic gluconeogenesis","volume":"363","author":"Zhang","year":"2012","journal-title":"Mol. Cell Endocrinol."},{"key":"10.1016\/j.atherosclerosis.2015.09.032_bib118","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.ijpharm.2014.03.017","article-title":"Amorphous solid dispersion of berberine with absorption enhancer demonstrates a remarkable hypoglycemic effect via improving its bioavailability","volume":"467","author":"Zhaojie","year":"2014","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.atherosclerosis.2015.09.032_bib119","doi-asserted-by":"crossref","first-page":"104","DOI":"10.3109\/03639045.2011.592531","article-title":"Enhancing effects of chitosan and chitosan hydrochloride on intestinal absorption of berberine in rats","volume":"38","author":"Chen","year":"2012","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.atherosclerosis.2015.09.032_bib120","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1208\/s12249-011-9632-z","article-title":"Bioavailability study of berberine and the enhancing effects of TPGS on intestinal absorption in rats","volume":"12","author":"Chen","year":"2011","journal-title":"AAPS Pharm. Sci. Tech."},{"key":"10.1016\/j.atherosclerosis.2015.09.032_bib121","first-page":"239749","article-title":"Berberine nanosuspension enhances hypoglycemic efficacy on streptozotocin induced diabetic C57BL\/6 mice","volume":"2015","author":"Wang","year":"2015","journal-title":"Evid. Based Complement. Altern. Med."},{"key":"10.1016\/j.atherosclerosis.2015.09.032_bib122","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1002\/bmc.2674","article-title":"Simultaneous quantification of berberine and lysergol by HPLC-UV: evidence that lysergol enhances the oral bioavailability of berberine in rats","volume":"26","author":"Patil","year":"2011","journal-title":"Biomed. Chromatogr."},{"key":"10.1016\/j.atherosclerosis.2015.09.032_bib123","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.ijbiomac.2013.04.074","article-title":"Effects of beta-cyclodextrin on the intestinal absorption of berberine hydrochloride, a P-glycoprotein substrate","volume":"59","author":"Zhang","year":"2013","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.atherosclerosis.2015.09.032_bib124","first-page":"516","article-title":"Preparation and evaluation of a microemulsion for oral delivery of berberine","volume":"63","author":"Gui","year":"2008","journal-title":"Pharmazie"},{"key":"10.1016\/j.atherosclerosis.2015.09.032_bib125","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ejps.2011.06.015","article-title":"Preparation of an anhydrous reverse micelle delivery system to enhance oral bioavailability and anti-diabetic efficacy of berberine","volume":"44","author":"Wang","year":"2011","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.atherosclerosis.2015.09.032_bib126","doi-asserted-by":"crossref","first-page":"499","DOI":"10.3109\/03639045.2012.683875","article-title":"Development of self-microemulsifying drug delivery system for oral bioavailability enhancement of berberine hydrochloride","volume":"39","author":"Zhu","year":"2013","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.atherosclerosis.2015.09.032_bib127","doi-asserted-by":"crossref","first-page":"4677","DOI":"10.2147\/IJN.S51262","article-title":"Characterization, pharmacokinetics, and hypoglycemic effect of berberine loaded solid lipid nanoparticles","volume":"8","author":"Xue","year":"2013","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.atherosclerosis.2015.09.032_bib128","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1021\/jm801157z","article-title":"Berberine analogues as a novel class of the low-density-lipoprotein receptor up-regulators: synthesis, structure-activity relationships, and cholesterol-lowering efficacy","volume":"52","author":"Li","year":"2009","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.atherosclerosis.2015.09.032_bib129","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.metabol.2012.09.009","article-title":"Berberine analogue IMB-Y53 improves glucose-lowering efficacy by averting cellular efflux especially P-glycoprotein efflux","volume":"62","author":"Shan","year":"2013","journal-title":"Metabolism"},{"key":"10.1016\/j.atherosclerosis.2015.09.032_bib130","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1007\/s11596-014-1256-6","article-title":"Intestinal absorption of berberine and 8-hydroxy dihydroberberine and their effects on sugar absorption in rat small intestine","volume":"34","author":"Wei","year":"2014","journal-title":"J.\u00a0Huazhong Univ. Sci. Technol. Med. Sci."},{"key":"10.1016\/j.atherosclerosis.2015.09.032_bib131","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1007\/s11655-014-1775-1","article-title":"Inhibition of proprotein convertase subtilisin\/kexin type 9: a novel mechanism of berberine and 8-hydroxy dihydroberberine against hyperlipidemia","volume":"21","author":"Liu","year":"2015","journal-title":"Chin. J. Integr. Med."},{"key":"10.1016\/j.atherosclerosis.2015.09.032_bib132","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.2337\/db07-1552","article-title":"Berberine and its more biologically available derivative, dihydroberberine, inhibit mitochondrial respiratory complex I: a mechanism for the action of berberine to activate AMP-activated protein kinase and improve insulin action","volume":"57","author":"Turner","year":"2008","journal-title":"Diabetes"},{"key":"10.1016\/j.atherosclerosis.2015.09.032_bib133","doi-asserted-by":"crossref","first-page":"5915","DOI":"10.1016\/j.bmc.2010.06.085","article-title":"8,8-Dimethyldihydroberberine with improved bioavailability and oral efficacy on obese and diabetic mouse models","volume":"18","author":"Cheng","year":"2010","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.atherosclerosis.2015.09.032_bib134","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1186\/s12967-014-0326-7","article-title":"Berberine derivatives reduce atherosclerotic plaque size and vulnerability in apoE(\u2212\/\u2212) mice","volume":"12","author":"Chen","year":"2014","journal-title":"J.\u00a0Transl. Med."}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915015301416?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915015301416?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,11]],"date-time":"2024-06-11T10:32:35Z","timestamp":1718101955000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915015301416"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":134,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["S0021915015301416"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2015.09.032","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2015,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Berberine, a plant alkaloid with lipid- and glucose-lowering properties: From in\u00a0vitro evidence to clinical studies","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2015.09.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}